logo
Select company
Select metric
$ -6.67MEnterprise Value
VS
Market
1
Sector
3
Industry
4
History
43
$ 1.42Close
$ 1.42 - $ 4.45 52-Week Range
Ticker Information

Ticker

APRE

Company Name

APREA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

APREA THERAPEUTICS INC - Enterprise Value Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

APRE - EV Historical data
DateCash and EquivalentsTotal DebtEnterprise ValueMarket Capitalization
6/30/2025$ 16.57M$ 0$ -6.67M$ 9.9M
3/31/2025$ 19.32M$ 0$ -10.85M$ 8.46M
12/31/2024$ 22.89M$ 0$ -10.86M$ 12.03M
9/30/2024$ 26.29M$ 0$ -4.66M$ 21.63M
6/30/2024$ 28.74M$ 0$ -11.25M$ 17.49M
3/31/2024$ 32.41M$ 0$ -426.99K$ 31.98M
12/31/2023$ 21.65M$ 0$ 10.5M$ 32.15M
9/30/2023$ 25.39M$ 0$ -10.26M$ 15.13M
6/30/2023$ 27.73M$ 0$ -12.85M$ 14.87M
3/31/2023$ 31M$ 0$ -17.34M$ 13.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • APREA THERAPEUTICS INC's latest trailing twelve months (TTM) EV stands at $ 331.44M.
  • Over the past 5 years, APREA THERAPEUTICS INC's average EV has been $ 15.17M.
  • The median EV for APREA THERAPEUTICS INC during this period was $ -8.47M
  • APREA THERAPEUTICS INC reached its highest EV over the past 5 years at $ 331.44M.
  • The lowest EV recorded by APREA THERAPEUTICS INC in the same timeframe $ -26.25M

APREA THERAPEUTICS INC's EV vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV Benchmarks
CompanyEV
LYRA : LYRA THERAPEUTICS INC $ 11.8MSXTP : 60 DEGREES PHARMACEUTICALS INC $ 3.73MBRTX : BIORESTORATIVE THERAPIES INC $ 10.17MVYNE : VYNE THERAPEUTICS INC $ -13.11MERNA : ERNEXA THERAPEUTICS INC $ 8.78MPAVM : PAVMED INC $ 15.31MCODX : CO-DIAGNOSTICS INC $ 797.28KLEXX : LEXARIA BIOSCIENCE CORP $ 11.84MPOAI : PREDICTIVE ONCOLOGY INC $ 11.08MHCWB : HCW BIOLOGICS INC $ 13M

Definition of Enterprise Value

[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
Market Cap + Debt - CashnEq
(=) EV
EV for APREA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 432.21M ] + Debt [ $ 377.08K ] - CashnEq [ $ 101.15M ]
(=) EV [ $ 331.44M ]

APRE - Enterprise Value, Last 5 years

$ -26.25M

Minimum

Mar 31, 2022

$ 331.44M

Maximum

Sep 30, 2020

$ 15.17M

Average

$ -8.47M

Median

EV Benchmark Analysis

The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
filtered constituents3.32K
min$ -1.69B
max$ 6.88B
average$ 1.25B
median$ 439.6M
std$ 1.67B